Status:

COMPLETED

Novel Methodology to Measure Protein Accumulation

Lead Sponsor:

Mayo Clinic

Conditions:

Aging

Eligibility:

All Genders

18+ years

Brief Summary

Accumulation of damaged proteins is thought to underlie many degenerative conditions, including aging, diabetes, Alzheimer's disease, cataracts, and others. Over time, proteins can be irreversibly dam...

Eligibility Criteria

Inclusion

  • Age 18-30 years
  • Age greater than 65 years

Exclusion

  • Active or uncontrolled cardiovascular disease
  • Chronic kidney disease with serum creatinine ≥ 1.4 mg/dL for women and ≥ 1.5 mg/dL for men
  • Chronic liver disease (elevation in serum transaminases ≥ 3 times the upper limit of normal)
  • Any debilitating chronic illness, including malignancy
  • Significant malabsorptive state, including prior gastric bypass surgery or inflammatory bowel disease
  • Diabetes mellitus (types 1 or 2) or glucose ≥ 110 mg/dL.
  • Obesity (BMI ≥ 31 kg/m2)
  • Anticoagulant therapy (warfarin or heparin) or bleeding disorder that increases risk of bleeding during a muscle biopsy.
  • Anemia (hemoglobin ≤ 11 g/dL)
  • Use of medications known to modulate protein synthesis, mitochondrial function, and/or glucose homeostasis (including β-blockers and corticosteroids).
  • Participation in another study where the 13CPhe was administered during the past 6 months.
  • Moderate or high level of structured exercise (on average, ≥ 30 minutes per day and ≥ 2 days per week)
  • Pregnancy
  • Daily use of tobacco products (smoking or chewing); or smoking ≥7 cigarettes per week, on average. Abstinence from tobacco for ≥3 months is required before enrollment in the study.

Key Trial Info

Start Date :

December 1 2011

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 1 2013

Estimated Enrollment :

24 Patients enrolled

Trial Details

Trial ID

NCT01505621

Start Date

December 1 2011

End Date

August 1 2013

Last Update

April 10 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Mayo Clinic

Rochester, Minnesota, United States, 55905

Novel Methodology to Measure Protein Accumulation | DecenTrialz